Ureteroscope Market Size

SkyQuest Technology's Ureteroscope market size, share and forecast Report is based on the analysis of market data and Industry trends impacting the global Ureteroscope Market and the revenue of top companies operating in it. Market Size Data and Statistics are based on the comprehensive research by our Team of Analysts and Industry experts.

Ureteroscope Market Insights

Global Ureteroscope Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.95 billion in 2024 to USD 1.49 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

Ureteroscopy, a minimally invasive process in which the ureteroscope is introduced to diagnose, examine, and treat the urinary tract, uses ureteroscopes. The urinary bladder and ureter are where this gadget operates. Individuals are more prone to chronic kidney conditions like kidney stones (urolithiasis), urethral stricture, and kidney cancer as a result of lifestyle changes, increasing consumption of alcoholic beverages and carbonated beverages, decreased water consumption, dietary changes, and lack of exercise.

Optical imaging technological developments and ongoing ureteroscope performance improvements are two of the major factors driving growth of the ureteroscope market. In order to reduce the chances of contamination and hospital-acquired illnesses, disposable ureteroscopes are frequently utilised. As a result, high-quality patient care is provided with improved financial feasibility. The use of ureteroscopies to treat urolithiasis, benign prostatic hyperplasia, and urothelial cancer is increasing in popularity. To reduce the risk of infections associated with ureteroscopy, regulatory authorities established strict regulations, which accelerated the development of disposable ureteroscopes.

US Ureteroscope Market is poised to grow at a sustainable CAGR for the next forecast year.

REQUEST FOR SAMPLE

Want to customize this report? REQUEST FREE CUSTOMIZATION

FAQs

Global Ureteroscope Market size was valued at USD 0.9 billion in 2023 and is poised to grow from USD 0.95 billion in 2024 to USD 1.49 billion by 2032, growing at a CAGR of 5.8% during the forecast period (2025-2032).

Players in the ureteroscopes market are concentrating on creating cutting-edge items to meet the escalating demand. For instance, Boston Scientific Corporation introduced the LithoVue Empower Retrieval Deployment Device in September 2018 for use with the disposable LithoVue Digital Flexible Ureteroscopes. The launch of the ureteroscope aScope 5 was announced by AMBU A/S in October 2017, and the product is scheduled to go on sale in 2021–2022. 'Olympus Corporation (Japan) ', 'Karl Storz SE & Co. KG (Germany) ', 'Boston Scientific Corporation (USA) ', 'Stryker Corporation (USA) ', 'Richard Wolf GmbH (Germany) ', 'Cook Medical (USA) ', 'Medtronic plc (Ireland) ', 'PENTAX Medical (Japan) ', 'Cogentix Medical (USA) ', 'Laborie Medical Technologies (Canada) ', 'Medi-Scope Endoscopy Co., Ltd. (China) ', 'Shenda Endoscope Co., Ltd. (China) ', 'KARL HAMMES GmbH & Co. KG (Germany) ', 'Ackermann Instrumente GmbH (Germany) ', 'Endo-Flex GmbH (Germany) ', 'Gimmi GmbH (Germany) ', 'Storz Endoskop Produktions GmbH (Germany) ', 'WISAP Medical Technology GmbH (Germany) ', 'Fujifilm Holdings Corporation (Japan) ', 'Conmed Corporation (USA)'

Ureteroscopes market is being driven by the rising prevalence of chronic kidney illnesses as well as the quick development of optical imaging and product performance. In 2021, the CDC reported that the prevalence of chronic renal disease was highest in people 65 years and older (38%) followed by people in the 45–64 age range (12%) and people between the ages of 18 and 44(6%). Chronic kidney disease is more likely to develop in those with cardiovascular disease and diabetes, which would directly affect the demand for minimally invasive procedures like ureteroscopy. The rate of procedures is expected to significantly rise, which will accelerate ureteroscopy adoption.

In order to reduce hospital-acquired infections, the usage of disposable ureter scopes has grown in the global ureteroscopes market. Additionally, these aid in lowering the possibility of contamination and lastly ensuring the provision of high-quality care to patients with improved financial feasibility. In addition, there has been a noteworthy rise in the need for ureteroscopies to treat prostatic hyperplasia, urolithiasis, and urothelial cancer. In order to reduce the risk of infections brought on by ureteroscopy, regulatory authorities have implemented a few strict requirements. In light of these elements, it has been predicted that the disposable ureteroscope market will expand in the next years.

North America is expected to rule the global ureteroscope market due to favorable reimbursement policies, state-of-the-art healthcare infrastructure, and well-established guidelines for the surgical and medical management of upper tract stone disease, all of which are expected to drive the market for ureteroscopes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Ureteroscope Market
Ureteroscope Market

Report ID: SQMIG20I2079

[email protected]
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE